50 Participants Needed

Hematopoiesis for Chronic Lymphocytic Leukemia

Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Mayo Clinic
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial examines how bone marrow (the soft tissue inside bones that produces blood cells) is affected in individuals with MBL (a condition with low levels of abnormal blood cells) and CLL (a type of blood cancer) compared to healthy individuals. The goal is to understand how these conditions alter the body's ability to fight infections. Participants will provide blood samples and may undergo a bone marrow biopsy (a small sample taken from the bone). This trial suits those diagnosed with MBL or CLL, regardless of treatment history, as well as healthy individuals over 40 without these conditions.

As an unphased trial, this study allows participants to contribute to foundational research that could enhance understanding and treatment of MBL and CLL.

Do I need to stop my current medications for the trial?

The trial does not specify if you need to stop your current medications. It includes people who are currently being treated, so you might be able to continue your medications.

Why are researchers excited about this trial?

Researchers are excited about this trial because it aims to uncover new insights into how blood formation, or hematopoiesis, differs in patients with Monoclonal B-cell Lymphocytosis (MBL) and Chronic Lymphocytic Leukemia (CLL) compared to healthy individuals. Unlike current treatments that primarily focus on managing symptoms or slowing disease progression, this study seeks to understand the underlying biological processes. By comparing blood and bone marrow samples from patients and healthy controls, researchers hope to identify potential new targets for future therapies, paving the way for more personalized and effective treatment strategies.

Who Is on the Research Team?

NE

Neil E. Kay, M.D.

Principal Investigator

Mayo Clinic in Rochester

Are You a Good Fit for This Trial?

Inclusion Criteria

I have not started any treatment yet.
I am currently receiving treatment.
I have already received treatment for my condition.
See 4 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Observational

Patients undergo blood sample collection and bone marrow aspiration and biopsy and have their medical records reviewed on study

Baseline

Follow-up

Participants are monitored for safety and effectiveness after observational procedures

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Non-Interventional Study

How Is the Trial Designed?

1

Treatment groups

Experimental Treatment

Group I: ObservationalExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Mayo Clinic

Lead Sponsor

Trials
3,427
Recruited
3,221,000+